Page last updated: 2024-08-23

1-deoxynojirimycin and choline

1-deoxynojirimycin has been researched along with choline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Devaney, E; Harnett, W; Nor, ZM1
Baumann, N; Billette de Villemeur, T; Feillet, F; Galanaud, D; Guffon, N; Heron, B; Lehéricy, S; Leveque, N; Sedel, F; Tourbah, A; Vanier, MT1
Audoin, B; Burzykowski, T; Chabrol, B; Galanaud, D; Kaphan, E; Sedel, F; Tourbah, A; Tranchant, C; Vanier, MT1

Other Studies

3 other study(ies) available for 1-deoxynojirimycin and choline

ArticleYear
The use of inhibitors of N-linked glycosylation and oligosaccharide processing to produce monoclonal antibodies against non-phosphorylcholine epitopes of Brugia pahangi excretory-secretory products.
    Parasitology research, 1997, Volume: 83, Issue:8

    Topics: 1-Deoxynojirimycin; Animals; Antibodies, Helminth; Antibodies, Monoclonal; Antigens, Helminth; Brugia pahangi; Choline; Epitopes, B-Lymphocyte; Gerbillinae; Glycosylation; Isotope Labeling; Oligosaccharides; Phosphorylcholine; Tritium; Tunicamycin

1997
24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy.
    Molecular genetics and metabolism, 2009, Volume: 96, Issue:2

    Topics: 1-Deoxynojirimycin; Adult; Brain; Choline; Cohort Studies; Creatine; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Niemann-Pick Disease, Type C; Treatment Outcome

2009
Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
    Journal of neurology, 2016, Volume: 263, Issue:5

    Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aspartic Acid; Brain; Choline; Disability Evaluation; Disease Progression; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Linear Models; Longitudinal Studies; Male; Niemann-Pick Disease, Type C; Patient Dropouts; Treatment Outcome; Young Adult

2016